Obstructive uropathy is rarely found to be a cause of acute kidney injury.
They may differ from hemodialysis patients with respect to case mix, volume status, disease management, and routine exposure to anticoagulation.
Tolvaptan slows kidney growth and renal decline.
New findings underscore the need for continued improvement in the recognition and management of patients with AKI.
An investigational drug that in early clinical studies looked like it could slow progression of CKD has been shown in two phase 3 clinical trials that it is no better than placebo.
Some higher-intensity statin formulations are associated with an increased risk of acute kidney injury (AKI).
Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with pediatric acute kidney injury (AKI).
High serum uric acid levels are a strong independent risk factor for acute kidney injury (AKI) after heart surgery.
Kidney disease independently increases pregnant women's risk of death.
Women with a history of hypertensive pregnancy disorders (HPD), including preeclampsia, may be at increased risk for renal disease later in life.
Metabolic syndrome (MetS) in patients with stage 3 and 4 CKD is associated with an increased risk of development of ESRD.
Unhealthy diets are not associated with more rapid declines in kidney function.
Patients initiating dialysis have a lower hospitalization risk in the first year if they start on peritoneal dialysis (PD) instead of hemodialysis (HD).
Hyponatremia is a relatively common electrolyte abnormality in the general U.S. adult population.
About 30% patients hospitalized for acute kidney injury (AKI) are readmitted for AKI within a year.